FindTrial
Sign In

Clinical study of thalidomide response in spondyloarthropathy patients

RETROSPECTIVE AND PROSPECTIVE ANALYSIS OF CLINICAL PROFILE OF PATIENTS OF CHRONIC SERONEGATIVE ARTHRITIS AND THEIR RESPONSE TO THALIDOMIDE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/035852
Enrollment
100
Registered
2021-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M45-M49- Spondylopathies

Interventions

None listed

Sponsors

INSTITUTE OF MEDICAL SCIENCE BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of spondyloathropathy according to ASAS criteria Above 16 years of age Able to give informed consent

Exclusion criteria

Exclusion criteria: Chronic illness(TB,Hematologic malignacies ,cardiac disease )that interfere with crp and esr measurements. Mechanical back pain Diagnosed case of peripheral neuropathy

Design outcomes

Primary

MeasureTime frame
Objective change in form of basdai change and crp and esr measurementsTimepoint: 6 months—

Secondary

MeasureTime frame
Patient requiring change of therapyTimepoint: 6 months—

Countries

India

Contacts

Public ContactSomil SINGH

INSTITUTE OF MEDICAL SCIENCE

Raimadhukar1508@gmail.com9721521619

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026